Back
The Chemours Vs. Novo Nordisk AS Industry Stock Comparison
Sell
22
CC
The Chemours
Last Price:
$17.61
Seasonality Move:
9.02%
Sell
18
NONOF
Novo Nordisk AS
Last Price:
$88.03
Seasonality Move:
6.72%
Sell
22
The Chemours (CC)
is a Sell
Is The Chemours a Buy, Sell or Hold?
-
The current The Chemours [CC] share price is $17.54. The Score for CC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
CC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.86. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CC Stock Price Chart
What is The Chemours's stock price today?
-
The The Chemours share price today is $17.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CC is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.86Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
CC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 32.02 | Sell |
Chaikin Money Flow: | 71932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.45 - 21.65) | Sell |
Bollinger Bands (100): | (17.99 - 20.57) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.61 | Sell |
Relative Strength Index (14 RSI): | 29.63 | Sell |
Chaikin Money Flow: | -16178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.97 - 111.89) | Sell |
Bollinger Bands (100): | (106.42 - 130.98) | Sell |
CC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.19 | Sell |
20-day SMA: | 20.09 | Sell |
50-day SMA: | 19.65 | Sell |
200-day SMA: | 22.53 | Sell |
8-day EMA: | 18.27 | Sell |
20-day EMA: | 19.24 | Sell |
50-day EMA: | 19.64 | Sell |
200-day EMA: | 22.16 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.02 | Sell |
20-day SMA: | 106 | Sell |
50-day SMA: | 108.66 | Sell |
200-day SMA: | 125.92 | Sell |
8-day EMA: | 98.92 | Sell |
20-day EMA: | 103.95 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.71 | Sell |
The Chemours Earnings Growth & CC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.79 per share, and an increase next year of $0.99 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
The Chemours Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |